Verrica Pharmaceuticals Inc (VRCA)
1.44
-0.09
(-5.88%)
USD |
NASDAQ |
Nov 04, 16:00
1.05
-0.39
(-27.08%)
After-Hours: 20:00
Verrica Pharmaceuticals Debt to Equity Ratio: -3.214 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | -3.214 |
| March 31, 2024 | 28.41 |
| December 31, 2023 | 2.169 |
| September 30, 2023 | 1.002 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2022 | 0.00 |
| June 30, 2022 | 2.589 |
| March 31, 2022 | 1.652 |
| December 31, 2021 | 1.279 |
| September 30, 2021 | 1.012 |
| June 30, 2021 | 0.7862 |
| March 31, 2021 | 0.658 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-3.214
Minimum
Jun 2024
28.41
Maximum
Mar 2024
2.596
Average
0.8942
Median
Debt to Equity Ratio Benchmarks
| Biomarin Pharmaceutical Inc | 0.1098 |
| Elite Pharmaceuticals Inc | 0.1317 |
| Eagle Pharmaceuticals Inc | -- |
| TELA Bio Inc | 14.22 |
| Terns Pharmaceuticals Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 52.01M |
| Total Liabilities (Quarterly) | 65.31M |
| Shareholders Equity (Quarterly) | -13.30M |
| Current Ratio | 2.360 |
| Net Debt Paydown Yield | -2.76% |